Abstract
Direct immobilization of functional proteins on gold nanoparticles (AuNPs) affects their structure and function. Changes may vary widely and range from strong inhibition to the enhancement of protein function. More often though the outcome of direct protein immobilization results in protein misfolding and the loss of protein activity. Additional complications arise when the protein being immobilized is a zymogen which requires and relies on additional protein–protein interactions to exert its function. Here we describe molecular design of a glutathione-S-transferase-Staphylokinase fusion protein (GST-SAK) and its conjugation to AuNPs. The multivalent AuNP-(GST-SAK)n complexes generated show plasminogen activation activity in vitro. The methods described are transferable and could be adapted for conjugation and functional analysis of other plasminogen activators, thrombolytic preparations or other functional enzymes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schofield CL, Haines AH, Field RA et al (2006) Silver and gold glyconanoparticles for colorimetric bioassays. Langmuir 22:6707–6711
Guarise C, Pasquato L, De Filippis V et al (2006) Gold nanoparticles-based protease assay. Proc Natl Acad Sci U S A 103:3978–3982
Cao YC, Jin R, Mirkin CA (2002) Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 297:1536–1540
Park SJ, Taton TA, Mirkin CA (2002) Array-based electrical detection of DNA with nanoparticle probes. Science 295:1503–1506
Du Y, Luo XL, Xu JJ et al (2007) A simple method to fabricate a chitosan-gold nanoparticles film and its application in glucose biosensor. Bioelectrochemistry 70:342–347
Boyer D, Tamarat P, Maali A et al (2002) Photothermal imaging of nanometer-sized metal articles among scatterers. Science 297:1160–1163
Zhang Q, Gong Y, Guo XJ et al (2018) Multifunctional gold nanoparticle-based fluorescence resonance energy-transfer probe for target drug delivery and cell fluorescence imaging. ACS Appl Mater Interfaces 10:34840–34848
Paciotti GF, Myer L, Weinreich D et al (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11:169–183
Salem AK, Searson PC, Leong KW (2003) Multifunctional nanorods for gene delivery. Nat Mater 10:668–671
Joshi HM, Bhumkar DR, Joshi K et al (2006) Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir 22:300–305
Peña B, Maldonado M, Bonham AJ et al (2019) Gold nanoparticle-functionalized reverse thermal gel for tissue engineering applications. ACS Appl Mater Interfaces 11:18671–18680
West JL, Halas NJ (2003) Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annu Rev Biomed Eng 5:285–292
Chen R, Riviere JE (2017) Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction. WIREs Nanomed Nanobiotechnol 9:e1440
Yin MM, Dong P, Chen WQ et al (2017) Thermodynamics and mechanisms of the interactions between ultrasmall fluorescent gold nanoclusters and human serum albumin, gamma-globulins, and transferrin: a spectroscopic approach. Langmuir 33:5108–5116
Bailes J, Gazi S, Ivanova R (2012) Effect of gold nanoparticle conjugation on the activity and stability of functional proteins. Methods Mol Biol 906:89–99
Lv M, Zhu E, Su Y et al (2009) Trypsin-gold nanoparticle conjugates: binding, enzymatic activity, and stability. Prep Biochem Biotechnol 39(4):429–438
Huang F, Huang CC, Chang HT (2003) Exploring the activity and specificity of gold nanoparticle-bound trypsin by capillary electrophoresis with laser-induced fluorescence detection. Langmuir 19(18):7498–7502
Zhao X, Hao F, Lu D et al (2015) Influence of the surface functional group density on the carbon-nanotube-induced α-chymotrypsin structure and activity alterations. ACS Appl Mater Interfaces 7:18880–18890
Pan Y, Neupane S, Farmakes J et al (2017) Probing the structural basis and adsorption mechanism of an enzyme on nano-sized protein carriers. Nanoscale 9:3512–3523
Halling PJ, Ulijn RV, Flitsch SL (2005) Understanding enzyme action on immobilised substrates. Curr Opin Biotechnol 16:385–392
Basso A, Braiuca P, Ebert C et al (2006) Properties and applications of supports for enzyme-mediated transformations in solid phase synthesis. J Chem Technol Biotechnol 81:1626–1640
Kolobanova SV, Filippova IY, Lysogorskaya EN (2001) The enzymatic segment condensation of peptides on a solid phase in organic medium. Bioorg Khim 27:347–351
Doeze RHP, Maltman BA, Egan CL et al (2004) Profiling primary protease specificity by peptide synthesis on a solid support. Angew Chem Int Ed 43:3138–3141
Cortez J, Vorobieva E, Gralheira D et al (2011) Bionanoconjugates of tyrosinase and peptide-derivatised gold nanoparticles for biosensing of phenolic compounds. J Nanopart Res 13:1101–1113
GE Healthcare Life Sciences (2014) GST Gene Fusion System Handbook. GE Healthcare Life Sciences Protein Purification Methods. https://cdn.gelifesciences.com/dmm3bwsv3/AssetStream.aspx?mediaformatid=10061&destinationid=10016&assetid=11873. Accessed 30 Jan 2018
Ferrari E, Darios F, Zhang F et al (2010) Binary polypeptide system for permanent and oriented protein immobilization. J Nanobiotechnology 8:9
Ma W, Saccardo A, Roccatano D et al (2018) Modular assembly of proteins on nanoparticles. Nat Commun 9:1489
Prasad B, Salunkhe SS, Padmanabhan S (2010) Novel self-cleavage activity of Staphylokinase fusion proteins: an interesting finding and its possible applications. Protein Expr Purif 69:191–197
Parry MA, Fernandez-Catalan C, Bergner A et al (1998) The ternary microplasmin-Staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol 5:917–923
Jespers L, Vanwetswinkel S, Lijnen HR et al (1999) Structural and functional basis of plasminogen activation by Staphylokinase. Thromb Haemost 81:479–485
Osamu M, Masashi S, Kisaku S et al (1995) Thrombolytic peptide, production thereof, and thrombolytic agent. United States Patent US 5,475,089, 12 Dec 1995
Ella KM, Sumathy K (2015) Chimeric Fusion Proteins. United States Patent US 8,968,728, 3 Mar 2015
Hoischen C, Gumpert J, Kujau JM et al (2001) Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products. Patent: WO 0166776-A2 13 Sep 2001
Wirsching F, Luge C, Schwienhorst A (2002) Modular design of a novel chimeric protein with combined thrombin inhibitory activity and plasminogen-activating potential. Mol Genet Metab 75:250–259
Szarka SJ, Sihota EG, Habibi HR et al (1999) Staphylokinase as a plasminogen activator component in recombinant fusion proteins. Appl Environ Microbiol 65:506–513
Yu A, Zhang C, Dong C et al (2008) Two characteristics of a recombinant fusion protein composed of Staphylokinase and hirudin: high thrombus affinity and thrombus-targeting release of anticoagulant activity. Chin J Biotechnol 24:1955–1961
Pulicherla KK, Kumar A, Gadupudi GS et al (2013) In vitro characterization of a multifunctional Staphylokinase variant with reduced reocclusion, produced from salt inducible E. coli GJ1158. Biomed Res Int 2013:297305
Icke C, Schlott B, Ager OO et al (2002) Fusion proteins with anticoagulant and fibrinolytic properties: functional studies and structural considerations. Mol Pharmacol 62:203–209
Maheshwari N, Sahni G (2015) Protein fusion constructs possessing thrombolytic and anticoagulant properties. United States Patent US 9,150,844, 6 Oct 2015
Hui J, Yu XJ, Cui XJ et al (2014) Construction of novel chimeric proteins through the truncation of SEC2 and Sak from Staphylococcus aureus. Biosci Biotechnol Biochem 78:1514–1521
Szemraj J, Zakrzeska A, Brown G et al (2011) New derivative of Staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats. Pharmacol Rep 63:1169–1179
Wu SC, Castellino FJ, Wong SL (2003) A fast-acting, modular-structured Staphylokinase fusion with Kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy. J Biol Chem 278:18199–18206
Van Zyl WB, Pretorius GH, Lamprecht S et al (2000) PLATSAK, a potent antithrombotic and fibrinolytic protein, inhibits arterial and venous thrombosis in a baboon model. Thromb Res 98:435–443
Schlott B, Guhrs KH, Hartmann M et al (1997) Staphylokinase requires NH2-terminal proteolysis for plasminogen activation. J Biol Chem 272:6067–6072
Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40
Landskroner K, Olson N, Jesmok G (2005) Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development. J Vasc Interv Radiol 16:369–377
Cederholm-Williams SA (1981) Concentration of plasminogen and antiplasmin in plasma and serum. J Clin Pathol 34:979–981
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dosadina, E. et al. (2020). Oriented Immobilization on Gold Nanoparticles of a Recombinant Therapeutic Zymogen. In: Ferrari, E., Soloviev, M. (eds) Nanoparticles in Biology and Medicine. Methods in Molecular Biology, vol 2118. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0319-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0319-2_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0318-5
Online ISBN: 978-1-0716-0319-2
eBook Packages: Springer Protocols